News Headlines

Display #
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human])
AbbVie Receives CHMP Positive Opinion for HUMIRA® (adalimumab) for the Treatment of Pediatric Patients with Chronic Non-infectious Anterior Uveitis
One minute of running per day associated with better bone health in women
Amgen and Array BioPharma announce preclinical license and collaboration agreement in inflammation
Gottlieb Lays Out Plans to Attract and Preserve Top Talent at the FDA
Puma Biotech Surges After the FDA Officially Approves Breast Cancer Drug
Nektar Announces Topline Data from HAP Study for NKTR-181
New way found to boost immunity in fight cancer and infections
Vertex Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials
FDA Green Lights Gilead’s Vosevi; Black-Box Warning Attached
FDA approves Vosevi for Hepatitis C
Senate Republicans reluctantly consider bipartisan healthcare talks
Novartis Boss Updates Q2 2017 Financials, Reaffirms M&A Strategy
Siemens Breaks Ground on $300 Million Expansion in Walpole, Mass., Plans for 700 New Jobs
EU watchdog concerned drug agency EMA may be too close to companies
Belgian doctors pin hope on large brain collection to treat diseases
CHMP Issues a Positive Opinion for Daiichi Sankyo’s Once-Daily Lixiana in Patients with Atrial Fibrillation Undergoing Cardioversion
Merck Biopharma Innovation Cup 2017
Radius Health’s Longtime CEO Out, Former Novo Nordisk Exec Named New Leader
Safety Issues Force the FDA to Turn Down Amgen, UCB’s Osteoporosis Drug
A new ligand extends the half-life of peptide drugs from minutes to days
Valeant Dumps Another Asset in Cash Deal
Smartphone Controlled Vision is Coming
Global health price tag could be $371 billion a year by 2030, WHO says
Artificial sweeteners may not be risk free
Doctors, nurses among hundreds charged with defrauding U.S. health programs
FDA Advisory Committee Unanimously Recommends Approval of Mylan and Biocon’s Proposed Biosimilar Trastuzumab
How to Lead in a “Do More with Less” Environment
Anthem files lawsuit against Insys Therapeutics
Cancer cells force normal cells to mimic viruses to help tumors spread, resist treatment